Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in complex oral solid dose, liquids, semi-solids, opthalmics, biologics, and sterile injectable products. We provide early phase clinical through to commercial manufacturing with full packaging capabilities to biopharma companies worldwide. Bora owns and operates in ten state-of-the-art CGMP manufacturing facilities across Asia and North America – delivering to more than 100 markets around the world. Our sites have the highest international standards for manufacturing, packaging, R&D and analytical testing. As a future focused CDMO, we know better than most that our own success is shaped by our partners victories. That's why, when you choose Bora - we make success more certain by following Bora’s 5Ps – Promises, Partnerships, Pride, People, and Progress. These 5 principles are Bora’s Pledge to our customers. Follow us to find out more and keep up to date with Bora Pharmaceuticals.
| Website | https://boracdmo.com |
| Revenue | $65 million |
| Employees | 694 (520 on RocketReach) |
| Founded | 2007 |
| Phone | +886 2 2790 1555 |
| Industry | Pharmaceutical Manufacturing, Pharmaceutical, Health Care |
| Keywords | Pharmaceutical Contract Manufacturing Organization, Cdmo Services, Pharmaceutical Manufacturing, Contract Manufacturing, Drug Product Manufacturing, Drug Development Outsourcing, Pharmaceutical Development, Custom Pharmaceutical Manufacturing, Drug Formulation Development, Dosage Form Development, Liquid Formulations, Semi-Solid Dosage Forms, Sterile Drug Manufacturing |
Looking for a particular Bora Pharmaceuticals employee's phone or email?
The Bora Pharmaceuticals annual revenue was $65 million in 2026.
Tom Chang is the Senior Vice President of Taiwan Manufacturing of Bora Pharmaceuticals.
520 people are employed at Bora Pharmaceuticals.